Sunday, December 7, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home ETF

The Hidden Tech Concentration Within a Global ETF

Robert Sasse by Robert Sasse
September 6, 2025
in ETF, Nasdaq, S&P 500, Tech & Software
0
MSCI World ETF Stock
0
SHARES
186
VIEWS
Share on FacebookShare on Twitter

A surprising trend is emerging within broad-market international funds: significant exposure to a handful of mega-cap technology stocks. The iShares MSCI World ETF (URTH) exemplifies this phenomenon, where the collective weight of just three companies—NVIDIA, Microsoft, and Apple—exceeds 14% of the entire portfolio. This substantial concentration presents a dual narrative of potent opportunity alongside inherent sector-specific risk.

Recent performance figures underscore the benefits of this tilt. Year-to-date, the fund has delivered an impressive 13.51% return, outpacing numerous international competitors. Its 12-month performance through July 2025 reached 16.50%, a figure that narrowly surpassed its benchmark, the MSCI World index, which returned 16.26%. The fund’s longer-term track record remains strong, with three-year annualized returns of 18.46% and five-year annualized gains averaging 14.73%. This momentum is further evidenced by its current trading price hovering just below its 52-week high.

Should investors sell immediately? Or is it worth buying MSCI World ETF?

A deeper look into the fund’s composition reveals the source of this performance. The top ten holdings collectively account for a substantial 26.2% of its total assets. Leading the pack is NVIDIA with a 5.42% weighting, followed by Microsoft at 4.56% and Apple at 4.43%. These three firms have been primary drivers of the fund’s gains in the current AI-fueled market environment. They are joined by other tech giants, including Amazon (2.79%) and Meta Platforms (2.05%), creating a distinctly technology-heavy profile. While this allocation accurately mirrors the market capitalization of the world’s largest companies, it also increases the ETF’s vulnerability to a potential downturn or rotation away from the technology sector. This US-centric tech reliance is also reflected in the fund’s geographic allocation, where American equities command a dominant share despite its global mandate.

Beyond its holdings, the ETF is structured for efficiency. It boasts high liquidity with approximately 325,000 shares traded daily and maintains tight bid-ask spreads. Its expense ratio is positioned competitively within the global equity ETF space. The central question for investors is whether this pronounced tech weighting will continue to serve as a durable engine for growth or eventually transform into a liability during a market shift.

Ad

MSCI World ETF Stock: Buy or Sell?! New MSCI World ETF Analysis from December 7 delivers the answer:

The latest MSCI World ETF figures speak for themselves: Urgent action needed for MSCI World ETF investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 7.

MSCI World ETF: Buy or sell? Read more here...

Tags: MSCI World ETF
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

XRP Stock
Analysis

Institutional Investors Accumulate XRP Amid Market Correction

December 6, 2025
Ethereum Stock
Analysis

Ethereum’s Fusaka Upgrade: A Technical Leap Amid Cautious Markets

December 6, 2025
Quantum eMotion Stock
Blockchain

Quantum eMotion Shares Pull Back Following Sharp Rally

December 6, 2025
Next Post
Uranium Energy Stock

Strategic Acquisition Positions Uranium Energy as US Nuclear Leader

Immunovant Inc Stock

Immunovant's Breakthrough Data Sparks Investor Optimism

Amazon Stock

Leadership Shifts at Amazon's AI Division Raise Strategic Questions

Recommended

Bristol-Myers Squibb Stock

Bristol-Myers Squibb: A Biopharma Giant at a Critical Juncture

2 months ago
Information Technology Stock Market Today

Understanding the Stock Symbol CRM Salesforce Inc

2 years ago
Tesla Stock

Tesla’s Robotaxi Push Accelerates Amid Mounting Legal Challenges

3 months ago
Aventis Energy Stock

Aventis Energy Stock: AI Uncovers Promising Uranium Targets

3 weeks ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Institutional Investors Accumulate XRP Amid Market Correction

Ethereum’s Fusaka Upgrade: A Technical Leap Amid Cautious Markets

Voestalpine Shares Approach Annual Peak on Strategic and Analyst Support

A Bet on Freedom: Michael Burry Takes Major Stake in Fannie Mae

Quantum eMotion Shares Pull Back Following Sharp Rally

Nasdaq 100 Rises on Rate Cut Hopes and Merger Buzz

Trending

Absci Stock
AI & Quantum Computing

Absci Stock Surges on Entry into Human Clinical Trials

by Dieter Jaworski
December 7, 2025
0

Shares of AI-driven biotechnology firm Absci experienced significant volatility following a key development in its research pipeline....

Cullinan Oncology LLC Stock

Cullinan Oncology Shares Present Significant Upside, Analysts Assert

December 7, 2025
Seritage Growth Properties Stock

Seritage Nears Full Repayment of Major Berkshire Hathaway Loan

December 6, 2025
XRP Stock

Institutional Investors Accumulate XRP Amid Market Correction

December 6, 2025
Ethereum Stock

Ethereum’s Fusaka Upgrade: A Technical Leap Amid Cautious Markets

December 6, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Absci Stock Surges on Entry into Human Clinical Trials
  • Cullinan Oncology Shares Present Significant Upside, Analysts Assert
  • Seritage Nears Full Repayment of Major Berkshire Hathaway Loan

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com